Title : Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.

Pub. Date : 2011 Mar 24

PMID : 21256121






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study examined the long term effects of the opioid growth factor (OGF, [Met(5)]-enkephalin) and a low dose of the opioid antagonist naltrexone (LDN) on expression of myelin oligodendrocyte glycoprotein (MOG)-induced EAE. Naltrexone myelin oligodendrocyte glycoprotein Mus musculus
2 This study examined the long term effects of the opioid growth factor (OGF, [Met(5)]-enkephalin) and a low dose of the opioid antagonist naltrexone (LDN) on expression of myelin oligodendrocyte glycoprotein (MOG)-induced EAE. Naltrexone myelin oligodendrocyte glycoprotein Mus musculus